New indicators for delay in initiation of antiretroviral treatment: estimates for CameroonJacques D.A. Ndawinz1,2 , Xavier Anglaret3,4,5, Eric Delaporte6,7, Sinata Koulla-Shiro8,9, Delphine Gabillard3,4,5 , Albert Minga3,10, Dominique Costagliola1,2, and Virginie Supervie1,2
1Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136 Pierre Louis Institute of Epidemiology and Public Health, F-75013, Paris, France,
2INSERM, UMR_S 1136 Pierre Louis Institute of Epidemiology and Public Health, F-75013, Paris, France,
3 Programme PACCI, Site ANRS, Abidjan, Côte d’Ivoire,
4Université Bordeaux, INSERM, IPSED, Centre INSERM U897-Epidémiologie et Biostatistique, F-33000 Bordeaux, France, 5INSERM, IPSED, Centre INSERM U897-Epidémiologie et Biostatistique, F-33000 Bordeaux, France,
6Department of Infectious and Tropical Diseases, University Hospital, F-34000, Montpellier, France,
7Institut de Recherche pour le Développement (IRD), University Montpellier 1, UMI 233, F-34000, Montpellier, France,
8Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon,
9Infectious Disease Unit, Yaoundé Central Hospital, Yaoundé, Cameroon,
10Centre Médical de Suivi de Donneurs de Sang (CMSDS), Abidjan, Côte d'Ivoire